Biaxin XL (R) (Clarithromycin extended-release tablets) and Levaquin(R) achieve similar results for community-acquired pneumonia

San Francisco, Calif., May 23, 2001 A new study comparing Biaxin XL(R) (clarithromycin extended-release tablets) and another leading, once-daily antibiotic, Levaquin(R) (levofloxacin tablets, Johnson & Johnson) shows that Biaxin XL and Levaquin had similar results in patients with community-acquired pneumonia (CAP). The results presented today at the 97th annual meeting of the American Thoracic Society showed that patients receiving Biaxin XL achieved a clinical cure rate of 88 percent, similar to those taking the quinolone, Levaquin, who achieved an 86 percent clinical cure rate.

Biaxin XL is the once-daily formulation of Abbott Laboratories widely prescribed, advanced-generation macrolide antibiotic, Biaxin(R)(clarithromycin tablets), and in March 2000 was approved by the U.S. Food and Drug Administration for the treatment of mild-to-moderate acute maxillary sinusitis and acute bacterial exacerbation of chronic bronchitis in adults. The efficacy and safety of Biaxin XL in treating other infections for which other formulations of Biaxin are approved have not been established.

These data are of interest because as many as three million Americans are affected each year by community-acquired pneumonia, said Dan Dattani, M.D., principal investigator, Prairie Clinical Research Group, assistant clinical professor of Family Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, and lead investigator in this study. These data show that Biaxin and Levaquin had similar results in patients with this respiratory infection.

Study Results

Biaxin XL and Levaquin were compared in a double-blind, parallel-group, multicenter study in 299 ambulatory patients with CAP. Patients were randomized to receive either 1,000 mg of Biaxin XL (2 x 500mg tablets) once-a-day for seven days, or 500 mg of Levaquin (2 x 250mg tablets) once-a-day for seven days. Efficacy evaluations were made at the test-of-cure visit (seven to 14 days after compl

Contact: Tina Brookhouse
Porter Novelli

Page: 1 2 3 4

Related medicine news :

1. Chemists honor Heroes for biotechnology achievements in health
2. New data demonstrates that Benicar(R) and Benicar HCT (TM) achieve JNC 7 blood pressure goals
3. St. Jude helps South American community achieve improved survival rates for leukemia
4. New data shows Seroquel achieves remission in bipolar mania
5. ISHLT to recognize transplant pioneer Dr. Magdi Yacoub with lifetime achievement award
6. Study finds elderly patients achieve seizure freedom on epilepsy therapy
7. Researcher at UCLAs Jonsson Cancer Center wins lifetime achievement award
8. Children achieve sustained ADHD symptom improvement with long-term, once-daily use of Adderall XR
9. Birth weight and social class linked to educational achievement
10. Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients
11. Emory vaccine study in South Africa achieves significant reductions in pneumonia

Post Your Comments:

(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are ... saves lives. However, if one isn’t accessible in certain locations, the risk of ... I came up with this idea," said an inventor from Ridgecrest, Calif. , ...
(Date:9/22/2017)... Long Island, New York (PRWEB) , ... September ... ... that manufactures, delivers and assembles Passive House buildings, and Richard Pedranti Architect ... next Prefabricated Passive House from the strategic partner’s Solsken Line of Model ...
(Date:9/22/2017)... ... 22, 2017 , ... Tiny Transitions ( tinytransitions.com ), an ... and online newborn sleep consultations . , “We are seeing now, more ... owner Courtney Zentz, a pediatric sleep professional, post-partum doula and certified lactation counselor. ...
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - ... - carries it into the entertaining and delicious worlds of theatre and wines. ... of Happy Living) convinced him to turn his play into a book. The Greener ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... fallacy of an obligatory tithe, and the freedom experienced when breaking free from ... of published author, Lysa M. Harrison. , Published by Christian Faith Publishing, Lysa ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... Sept. 7, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... at the Grand Hyatt hotel in New York.  Zimmer ... 11:40 a.m. Eastern Time. A live webcast ... Investor Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology:
Cached News: